SEC Tracker
Get the app

Jazz Pharmaceuticals JAZZ

Jazz Pharmaceuticals: quarterly report for the quarter ended Sep 30, 2023

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Jazz Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  2. Repligen RGEN public float $6.0B, Jun 30, 2025
  3. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  4. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.